TFX
Teleflex Incorporated
Price Chart
Latest Quote
$126.01
+1.05 (+0.84%)
Current Price
| Previous Close | $124.96 |
| Open | $125.50 |
| Day High | $127.30 |
| Day Low | $124.29 |
| Volume | 204,209 |
Stock Information
| Quarterly Dividend / Yield | $1.36 / 1.06% |
| Shares Outstanding | 44.27M |
| Quarterly Dividend Yield | 1.06% |
| Quarterly Dividend | $1.36 |
| Total Debt | $2.74B |
| Cash Equivalents | $333.06M |
| Revenue | $2.13B |
| Net Income | $1.36M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $5.58B |
| P/E Ratio | 2100.17 |
| EPS (TTM) | $0.06 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $8.07B |
| Sales | $2.13B |
| Income | $1.36M |
| Book/sh | $69.68 |
| Cash/sh | $7.52 |
| Employees | 16K |
Financial Ratios
| Quick Ratio | 0.96 |
| Current Ratio | 2.55 |
| Debt/Eq | 88.79 |
Returns & Margins
| ROA | 2.33% |
| ROE | 0.04% |
| Gross Margin | 55.33% |
| Operating Margin | 8.36% |
| Profit Margin | -47.43% |
Ownership
| Insider Ownership | 0.47% |
| Institutional Ownership | 111.01% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 11.95 |
| PEG | 0.16 |
| P/S | 2.62 |
| P/B | 1.81 |
Analyst Data
| Recommendation | hold |
| Target Price | $145.89 |
Technical Indicators
| SMA20 | $129.81 |
| SMA50 | $129.11 |
| SMA200 | $119.64 |
| RSI | 45.97 |
| ATR | 4.0414 |
| Shares Float | 44.11M |
| Short Float | 8.25% |
| Short Ratio | 3.07 |
| Volatility | 0.82 |
| Rel Volume | 0.35 |
Performance History
| Week | -2.55% |
| Month | -4.82% |
| Quarter | +18.02% |
| 6 Months | +1.47% |
| YTD | +3.51% |
| Year | +8.44% |
| 3 Years | -45.89% |
| 5 Years | -66.81% |
| 10 Years | -22.24% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $126.01 | 204,209 |
| 2026-06-17 | $124.96 | 427,100 |
| 2026-06-16 | $127.87 | 426,400 |
| 2026-06-15 | $130.09 | 437,400 |
| 2026-06-12 | $130.48 | 391,300 |
| 2026-06-11 | $129.31 | 549,300 |
| 2026-06-10 | $132.15 | 517,000 |
| 2026-06-09 | $135.75 | 579,500 |
| 2026-06-08 | $131.74 | 413,300 |
| 2026-06-05 | $129.84 | 723,500 |
| 2026-06-04 | $132.11 | 481,200 |
| 2026-06-03 | $128.56 | 660,100 |
| 2026-06-02 | $125.24 | 652,400 |
| 2026-06-01 | $127.57 | 854,900 |
| 2026-05-29 | $128.64 | 549,500 |
| 2026-05-28 | $129.66 | 794,100 |
| 2026-05-27 | $130.06 | 637,100 |
| 2026-05-26 | $131.89 | 1,057,700 |
| 2026-05-22 | $132.75 | 648,600 |
| 2026-05-21 | $131.56 | 624,400 |
| 2026-05-20 | $134.83 | 641,700 |
| 2026-05-19 | $132.40 | 744,200 |
| 2026-05-18 | $130.07 | 796,800 |
About Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
đ° Latest News
Surgical Equipment & Consumables - Specialty Stocks Q1 Recap: Benchmarking Teleflex (NYSE:TFX)
StockStory âĸ 2026-06-17T16:12:51Z
Here's How Innovation Fuels Globus Medical's Growth Momentum
Zacks âĸ 2026-06-15T14:32:00Z
Teleflex Freesolve Data Underscores Cardiology Ambitions And Debt Refinancing Trade Off
Simply Wall St. âĸ 2026-06-09T20:11:56Z
Sector Update: Healthcare Stocks Rise Pre-Bell Tuesday
MT Newswires âĸ 2026-06-09T13:18:04ZCerebras initiated, Crocs upgraded: Wall Street's top analyst calls
The Fly âĸ 2026-06-08T14:08:38Z
3 Reasons to Sell TFX and 1 Stock to Buy Instead
StockStory âĸ 2026-06-05T21:12:14Z
Here's How Financial Strength Remains a Key Advantage for GMED
Zacks âĸ 2026-06-04T15:55:00Z
Teleflex Urology Data Highlights Outcome Gains And Raises Valuation Questions
Simply Wall St. âĸ 2026-06-04T03:16:53Z
TFX Stock Setup: Valuation, Leverage, and a Neutral Zacks Rank
Zacks âĸ 2026-06-01T14:13:00Z
GMED's Robotics Leasing Shift Could Build Recurring Revenue
Zacks âĸ 2026-05-29T13:52:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $871,959,000 | $662,159,000 | $672,329,000 | $1,259,954,000 |
| Cost Of Revenue | $871,959,000 | $662,159,000 | $672,329,000 | $1,259,954,000 |
| Total Revenue | $1,992,713,000 | $1,699,546,000 | $1,712,441,000 | $2,791,041,000 |
| Operating Revenue | $1,992,713,000 | $1,699,546,000 | $1,712,441,000 | $2,791,041,000 |
| Expenses | ||||
| Interest Expense | $100,223,000 | $83,513,000 | $85,014,000 | $54,264,000 |
| Total Expenses | $1,736,909,000 | $1,445,700,000 | $1,408,696,000 | $2,277,521,000 |
| Other Income Expense | $-137,431,000 | $-150,195,000 | $-45,020,000 | $-14,249,000 |
| Net Non Operating Interest Income Expense | $-93,820,000 | $-77,361,000 | $-73,335,000 | $-53,352,000 |
| Interest Expense Non Operating | $100,223,000 | $83,513,000 | $85,014,000 | $54,264,000 |
| Operating Expense | $864,950,000 | $783,541,000 | $736,367,000 | $1,017,567,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $58,530,000 | $57,191,000 | $143,517,000 | $362,916,000 |
| Net Interest Income | $-93,820,000 | $-77,361,000 | $-73,335,000 | $-53,352,000 |
| Interest Income | $6,403,000 | $6,152,000 | $11,679,000 | $912,000 |
| Normalized Income | $167,100,490 | $175,845,050 | $178,368,585 | $374,512,703 |
| Net Income From Continuing And Discontinued Operation | $-905,640,000 | $69,675,000 | $356,328,000 | $363,139,000 |
| Total Operating Income As Reported | $118,373,000 | $103,651,000 | $258,725,000 | $499,725,000 |
| Net Income Common Stockholders | $-905,640,000 | $69,675,000 | $356,328,000 | $363,139,000 |
| Net Income | $-905,640,000 | $69,675,000 | $356,328,000 | $363,139,000 |
| Net Income Including Noncontrolling Interests | $-905,640,000 | $69,675,000 | $356,328,000 | $363,139,000 |
| Net Income Discontinuous Operations | $-964,170,000 | $12,484,000 | $212,811,000 | $223,000 |
| Net Income Continuous Operations | $58,530,000 | $57,191,000 | $143,517,000 | $362,916,000 |
| Pretax Income | $24,553,000 | $26,290,000 | $185,390,000 | $445,919,000 |
| Special Income Charges | $-137,431,000 | $-150,195,000 | $-45,020,000 | $-14,249,000 |
| Interest Income Non Operating | $6,403,000 | $6,152,000 | $11,679,000 | $912,000 |
| Operating Income | $255,804,000 | $253,846,000 | $303,745,000 | $513,520,000 |
| Gross Profit | $1,120,754,000 | $1,037,387,000 | $1,040,112,000 | $1,531,087,000 |
| Per Share | ||||
| Diluted EPS | $-20.30 | $1.48 | $7.53 | $7.68 |
| Basic EPS | $-20.30 | $1.49 | $7.58 | $7.74 |
| Other | ||||
| Tax Effect Of Unusual Items | $-28,860,510 | $-31,540,950 | $-10,168,415 | $-2,652,297 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $439,945,000 | $421,532,000 | $463,529,000 | $745,022,000 |
| Total Unusual Items | $-137,431,000 | $-150,195,000 | $-45,020,000 | $-14,249,000 |
| Total Unusual Items Excluding Goodwill | $-137,431,000 | $-150,195,000 | $-45,020,000 | $-14,249,000 |
| Reconciled Depreciation | $177,738,000 | $161,534,000 | $148,105,000 | $230,590,000 |
| EBITDA (Bullshit earnings) | $302,514,000 | $271,337,000 | $418,509,000 | $730,773,000 |
| EBIT | $124,776,000 | $109,803,000 | $270,404,000 | $500,183,000 |
| Diluted Average Shares | $44,724,000 | $47,094,000 | $47,304,000 | $47,309,000 |
| Basic Average Shares | $44,622,000 | $46,837,000 | $46,981,000 | $46,898,000 |
| Diluted NI Availto Com Stockholders | $-905,640,000 | $69,675,000 | $356,328,000 | $363,139,000 |
| Tax Provision | $-33,977,000 | $-30,901,000 | $41,873,000 | $83,003,000 |
| Gain On Sale Of Ppe | $0 | $0 | $4,448,000 | - |
| Write Off | $108,117,000 | $7,834,000 | $0 | $1,497,000 |
| Restructuring And Mergern Acquisition | $29,314,000 | $9,629,000 | $4,224,000 | $18,802,000 |
| Research And Development | $144,781,000 | $109,021,000 | $113,627,000 | $153,819,000 |
| Selling General And Administration | $720,169,000 | $674,520,000 | $622,740,000 | $863,748,000 |
| Gain On Sale Of Business | - | $0 | $4,448,000 | $6,504,000 |
| Other Special Charges | - | $132,732,000 | $45,244,000 | $454,000 |
| Impairment Of Capital Assets | - | $240,000,000 | $0 | $0 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-704,432,000 | $937,542,000 | $-975,027,000 | $-820,927,000 |
| Total Assets | $6,947,239,000 | $7,097,914,000 | $7,532,546,000 | $6,928,063,000 |
| Total Non Current Assets | $5,008,901,000 | $5,626,790,000 | $6,125,140,000 | $5,517,080,000 |
| Other Non Current Assets | $577,010,000 | $1,872,732,000 | $98,943,000 | $89,367,000 |
| Non Current Deferred Assets | $12,593,000 | $9,285,000 | $6,748,000 | $6,402,000 |
| Non Current Deferred Taxes Assets | $12,593,000 | $9,285,000 | $6,748,000 | $6,402,000 |
| Goodwill And Other Intangible Assets | $3,829,200,000 | $3,340,598,000 | $5,416,015,000 | $4,842,895,000 |
| Other Intangible Assets | $1,524,150,000 | $1,348,420,000 | $2,501,960,000 | $2,306,165,000 |
| Current Assets | $1,938,338,000 | $1,471,124,000 | $1,407,406,000 | $1,410,983,000 |
| Other Current Assets | $150,678,000 | $101,788,000 | $107,471,000 | $125,084,000 |
| Assets Held For Sale Current | $639,552,000 | $584,528,000 | - | - |
| Prepaid Assets | $19,566,000 | $3,457,000 | $7,404,000 | $6,524,000 |
| Inventory | $404,395,000 | $306,766,000 | $626,216,000 | $578,507,000 |
| Receivables | $345,583,000 | $226,733,000 | $443,467,000 | $408,834,000 |
| Accounts Receivable | $345,583,000 | $226,733,000 | $443,467,000 | $408,834,000 |
| Allowance For Doubtful Accounts Receivable | $-4,000,000 | $-4,700,000 | $-9,500,000 | $-8,600,000 |
| Gross Accounts Receivable | $349,583,000 | $231,433,000 | $452,967,000 | $417,434,000 |
| Cash Cash Equivalents And Short Term Investments | $378,564,000 | $247,852,000 | $222,848,000 | $292,034,000 |
| Cash And Cash Equivalents | $378,564,000 | $247,852,000 | $222,848,000 | $292,034,000 |
| Debt | ||||
| Net Debt | $2,262,885,000 | $1,408,019,000 | $1,592,224,000 | $1,419,489,000 |
| Total Debt | $2,725,659,000 | $1,743,829,000 | $1,926,372,000 | $1,831,960,000 |
| Long Term Debt And Capital Lease Obligation | $2,625,659,000 | $1,643,829,000 | $1,838,872,000 | $1,744,460,000 |
| Long Term Debt | $2,541,449,000 | $1,555,871,000 | $1,727,572,000 | $1,624,023,000 |
| Current Debt And Capital Lease Obligation | $100,000,000 | $100,000,000 | $87,500,000 | $87,500,000 |
| Current Debt | $100,000,000 | $100,000,000 | $87,500,000 | $87,500,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,822,471,000 | $2,819,774,000 | $3,091,558,000 | $2,906,095,000 |
| Total Non Current Liabilities Net Minority Interest | $3,060,445,000 | $2,170,414,000 | $2,484,813,000 | $2,324,603,000 |
| Other Non Current Liabilities | $198,068,000 | $120,267,000 | $165,872,000 | $159,863,000 |
| Liabilities Heldfor Sale Non Current | $52,969,000 | $110,863,000 | - | - |
| Non Current Deferred Liabilities | $183,749,000 | $295,455,000 | $456,080,000 | $388,886,000 |
| Non Current Deferred Taxes Liabilities | $183,749,000 | $295,455,000 | $456,080,000 | $388,886,000 |
| Current Liabilities | $762,026,000 | $649,360,000 | $606,745,000 | $581,492,000 |
| Other Current Liabilities | $265,515,000 | $195,331,000 | $46,547,000 | $63,381,000 |
| Payables And Accrued Expenses | $396,511,000 | $354,029,000 | $472,698,000 | $430,611,000 |
| Interest Payable | $5,404,000 | $5,338,000 | $5,583,000 | $5,332,000 |
| Payables | $148,988,000 | $139,021,000 | $173,700,000 | $151,543,000 |
| Total Tax Payable | $18,787,000 | $41,163,000 | $41,453,000 | $24,736,000 |
| Income Tax Payable | $18,787,000 | $41,163,000 | $41,453,000 | $24,736,000 |
| Accounts Payable | $130,201,000 | $97,858,000 | $132,247,000 | $126,807,000 |
| Equity | ||||
| Common Stock Equity | $3,124,768,000 | $4,278,140,000 | $4,440,988,000 | $4,021,968,000 |
| Total Equity Gross Minority Interest | $3,124,768,000 | $4,278,140,000 | $4,440,988,000 | $4,021,968,000 |
| Stockholders Equity | $3,124,768,000 | $4,278,140,000 | $4,440,988,000 | $4,021,968,000 |
| Gains Losses Not Affecting Retained Earnings | $-239,468,000 | $-316,669,000 | $-314,405,000 | $-403,522,000 |
| Other Equity Adjustments | $-239,468,000 | $-316,669,000 | $-314,405,000 | $-403,522,000 |
| Retained Earnings | $3,149,760,000 | $4,115,870,000 | $4,109,736,000 | $3,817,304,000 |
| Other | ||||
| Treasury Shares Number | $4,003,000 | $1,822,000 | $1,006,000 | $1,032,000 |
| Ordinary Shares Number | $44,194,408 | $46,273,734 | $47,040,000 | $46,925,000 |
| Share Issued | $48,197,408 | $48,095,734 | $48,046,000 | $47,957,000 |
| Tangible Book Value | $-704,432,000 | $937,542,000 | $-975,027,000 | $-820,927,000 |
| Invested Capital | $5,766,217,000 | $5,934,011,000 | $6,256,060,000 | $5,733,491,000 |
| Working Capital | $1,176,312,000 | $821,764,000 | $800,661,000 | $829,491,000 |
| Capital Lease Obligations | $84,210,000 | $87,958,000 | $111,300,000 | $120,437,000 |
| Total Capitalization | $5,666,217,000 | $5,834,011,000 | $6,168,560,000 | $5,645,991,000 |
| Treasury Stock | $649,534,000 | $350,341,000 | $152,101,000 | $154,889,000 |
| Additional Paid In Capital | $815,813,000 | $781,184,000 | $749,712,000 | $715,118,000 |
| Capital Stock | $48,197,000 | $48,096,000 | $48,046,000 | $47,957,000 |
| Common Stock | $48,197,000 | $48,096,000 | $48,046,000 | $47,957,000 |
| Long Term Capital Lease Obligation | $84,210,000 | $87,958,000 | $111,300,000 | $120,437,000 |
| Current Accrued Expenses | $247,523,000 | $215,008,000 | $298,998,000 | $279,068,000 |
| Goodwill | $2,305,050,000 | $1,992,178,000 | $2,914,055,000 | $2,536,730,000 |
| Net PPE | $590,098,000 | $404,175,000 | $603,434,000 | $578,416,000 |
| Accumulated Depreciation | $-470,055,000 | $-409,421,000 | $-573,165,000 | $-556,682,000 |
| Gross PPE | $1,060,153,000 | $813,596,000 | $1,176,599,000 | $1,135,098,000 |
| Construction In Progress | $131,087,000 | $82,389,000 | $94,633,000 | $76,077,000 |
| Other Properties | $91,817,000 | $95,714,000 | $123,521,000 | $131,211,000 |
| Machinery Furniture Equipment | $532,836,000 | $451,786,000 | $673,841,000 | $655,232,000 |
| Properties | $304,413,000 | $183,707,000 | $284,604,000 | $272,578,000 |
| Finished Goods | $260,019,000 | $198,997,000 | $335,567,000 | $292,873,000 |
| Work In Process | $54,368,000 | $37,699,000 | $111,132,000 | $98,993,000 |
| Raw Materials | $90,008,000 | $70,070,000 | $179,517,000 | $186,641,000 |
| Employee Benefits | - | $20,185,000 | $23,989,000 | $31,394,000 |
| Non Current Pension And Other Postretirement Benefit Plans | - | $20,185,000 | $23,989,000 | $31,394,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $245,441,000 | $545,301,000 | $464,217,000 | $262,951,000 |
| Operating Activities | ||||
| Operating Cash Flow | $340,677,000 | $635,738,000 | $510,638,000 | $342,141,000 |
| Cash From Discontinued Operating Activities | $243,995,000 | $333,856,000 | $304,500,000 | $-665,000 |
| Cash Flow From Continuing Operating Activities | $96,682,000 | $301,882,000 | $206,138,000 | $342,806,000 |
| Operating Gains Losses | $-82,636,000 | $132,732,000 | $40,796,000 | $-6,050,000 |
| Investing Activities | ||||
| Capital Expenditure | $-95,236,000 | $-90,437,000 | $-46,421,000 | $-79,190,000 |
| Investing Cash Flow | $-849,191,000 | $-99,358,000 | $-621,228,000 | $-257,941,000 |
| Cash From Discontinued Investing Activities | $-36,538,000 | $-35,997,000 | $-648,491,000 | $1,469,000 |
| Cash Flow From Continuing Investing Activities | $-812,653,000 | $-63,361,000 | $27,263,000 | $-259,410,000 |
| Net Other Investing Changes | $91,650,000 | - | - | - |
| Capital Expenditure Reported | $-95,236,000 | $-90,437,000 | $-46,421,000 | $-79,190,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-300,000,000 | $-200,000,000 | $0 | $0 |
| Financing Cash Flow | $611,539,000 | $-421,925,000 | $38,540,000 | $-217,506,000 |
| Cash Flow From Continuing Financing Activities | $611,539,000 | $-421,925,000 | $38,540,000 | $-217,506,000 |
| Net Other Financing Charges | $-22,360,000 | $-236,000 | $-4,004,000 | $-9,159,000 |
| Cash Dividends Paid | $-60,268,000 | $-63,541,000 | $-63,896,000 | $-63,789,000 |
| Net Common Stock Issuance | $-300,000,000 | $-200,000,000 | $0 | $0 |
| Common Stock Dividend Paid | - | $-63,541,000 | $-63,896,000 | $-63,789,000 |
| Issuance Of Capital Stock | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-153,000,000 | $-291,500,000 | $-544,750,000 | $-884,500,000 |
| Issuance Of Debt | $1,140,000,000 | $130,000,000 | $646,000,000 | $744,250,000 |
| Interest Paid Supplemental Data | $119,337,000 | $98,376,000 | $100,218,000 | $70,918,000 |
| End Cash Position | $402,680,000 | $285,314,000 | $192,732,000 | $292,034,000 |
| Other Cash Adjustment Outside Changein Cash | $-51,168,000 | $-42,335,000 | $-30,116,000 | - |
| Beginning Cash Position | $327,649,000 | $222,848,000 | $292,034,000 | $445,084,000 |
| Effect Of Exchange Rate Changes | $23,174,000 | $-9,654,000 | $2,864,000 | $-19,744,000 |
| Changes In Cash | $103,025,000 | $114,455,000 | $-72,050,000 | $-133,306,000 |
| Proceeds From Stock Option Exercised | $7,167,000 | $3,352,000 | $5,190,000 | $-4,308,000 |
| Common Stock Payments | $-300,000,000 | $-200,000,000 | $0 | $0 |
| Net Issuance Payments Of Debt | $987,000,000 | $-161,500,000 | $101,250,000 | $-140,250,000 |
| Net Long Term Debt Issuance | $987,000,000 | $-161,500,000 | $101,250,000 | $-140,250,000 |
| Long Term Debt Payments | $-153,000,000 | $-291,500,000 | $-544,750,000 | $-884,500,000 |
| Long Term Debt Issuance | $1,140,000,000 | $130,000,000 | $646,000,000 | $744,250,000 |
| Interest Received Cfi | $21,078,000 | $27,196,000 | $63,134,000 | $20,775,000 |
| Net Investment Purchase And Sale | $-5,000,000 | $0 | $-4,000,000 | $-15,000,000 |
| Sale Of Investment | $0 | $7,300,000 | $7,300,000 | $7,300,000 |
| Purchase Of Investment | $-5,000,000 | $-7,300,000 | $-11,300,000 | $-22,300,000 |
| Net Business Purchase And Sale | $-825,145,000 | $-120,000 | $14,550,000 | $-185,995,000 |
| Sale Of Business | $6,712,000 | $0 | $15,000,000 | $12,434,000 |
| Purchase Of Business | $-831,857,000 | $-120,000 | $-450,000 | $-198,429,000 |
| Taxes Refund Paid | $-35,727,000 | $-27,114,000 | $-18,653,000 | - |
| Change In Working Capital | $-45,361,000 | $47,395,000 | $-84,765,000 | $-239,964,000 |
| Change In Payables And Accrued Expense | $-8,284,000 | $2,346,000 | $-18,927,000 | $-24,786,000 |
| Change In Payable | $-8,284,000 | $2,346,000 | $-18,927,000 | $-24,786,000 |
| Change In Account Payable | $-8,284,000 | $2,346,000 | $-18,927,000 | $-24,786,000 |
| Change In Prepaid Assets | $-35,585,000 | $41,906,000 | $-5,022,000 | $13,420,000 |
| Change In Inventory | $84,041,000 | $6,746,000 | $-56,439,000 | $-110,686,000 |
| Change In Receivables | $-85,533,000 | $-3,603,000 | $-4,377,000 | $-38,459,000 |
| Changes In Account Receivables | $-85,533,000 | $-3,603,000 | $-4,377,000 | $-38,459,000 |
| Other Non Cash Items | $955,463,000 | $-2,927,000 | $-255,053,000 | $-20,622,000 |
| Stock Based Compensation | $25,695,000 | $25,960,000 | $27,301,000 | $27,224,000 |
| Asset Impairment Charge | $108,117,000 | $7,834,000 | $0 | $1,497,000 |
| Deferred Tax | $-100,967,000 | $-113,207,000 | $-7,921,000 | $-13,008,000 |
| Deferred Income Tax | $-100,967,000 | $-113,207,000 | $-7,921,000 | $-13,008,000 |
| Depreciation Amortization Depletion | $177,738,000 | $161,534,000 | $148,105,000 | $230,590,000 |
| Depreciation And Amortization | $177,738,000 | $161,534,000 | $148,105,000 | $230,590,000 |
| Amortization Cash Flow | $121,656,000 | $108,780,000 | $102,617,000 | $164,088,000 |
| Amortization Of Intangibles | $121,656,000 | $108,780,000 | $102,617,000 | $164,088,000 |
| Depreciation | $56,082,000 | $52,754,000 | $45,488,000 | $66,502,000 |
| Pension And Employee Benefit Expense | $0 | $132,732,000 | $45,244,000 | $0 |
| Gain Loss On Investment Securities | $-82,636,000 | - | - | - |
| Net Income From Continuing Operations | $-905,640,000 | $69,675,000 | $356,328,000 | $363,139,000 |
| Income Tax Paid Supplemental Data | - | $164,902,000 | $114,211,000 | $162,046,000 |
| Change In Other Working Capital | - | $-28,486,000 | $-12,263,000 | $-79,453,000 |
Fetched: 2026-06-17